Identification of functional pathways for regenerative bioactivity of selected renal cells

BACKGROUND: Selected renal cells (SRC) are in Phase II clinical trials as a kidney-sourced, autologous, tubular epithelial cell-enriched cell-based therapy for chronic kidney disease (CKD). In preclinical studies with rodent models of CKD, SRC have been shown to positively modulate key renal biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Sha, Wei, Bertram, Timothy, Jain, Deepak, Brouwer, Cory, Basu, Joydeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851708/
https://www.ncbi.nlm.nih.gov/pubmed/35177125
http://dx.doi.org/10.1186/s13287-022-02713-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851708/
https://www.ncbi.nlm.nih.gov/pubmed/35177125
http://dx.doi.org/10.1186/s13287-022-02713-6

Ejemplares similares